Gastrointestinal (GI) infections present a formidable challenge to healthcare systems. As we navigate this landscape, we recognize that there are numerous benefits when moving from conventional to molecular testing for GI pathogens, including faster turnaround time, improved sensitivity, and more efficient laboratory workflow.

 

When transitioning to molecular testing, laboratories are faced with the choice between large, comprehensive panels or targeted, class-specific panels. There are multiple factors for a laboratory to consider when choosing between these options.

 

In this webinar, you will hear from two experienced clinical microbiologists on their selection criteria for molecular panels for GI testing, the impact on the management of patients, and the role diagnostic stewardship plays in their laboratory testing practices.

 

Learning Objectives